Literature DB >> 19075578

Oxidative stress signaling in Alzheimer's disease.

B Su1, X Wang, A Nunomura, P I Moreira, H-gon Lee, G Perry, M A Smith, X Zhu.   

Abstract

Multiple lines of evidence demonstrate that oxidative stress is an early event in Alzheimer's disease (AD), occurring prior to cytopathology, and therefore may play a key pathogenic role in AD. Oxidative stress not only temporally precedes the pathological lesions of the disease but also activates cell signaling pathways, which, in turn, contribute to lesion formation and, at the same time, provoke cellular responses such as compensatory upregulation of antioxidant enzymes found in vulnerable neurons in AD. In this review, we provide an overview of the evidence of oxidative stress and compensatory responses that occur in AD, particularly focused on potential sources of oxidative stress and the roles and mechanism of activation of stress-activated protein kinase pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19075578      PMCID: PMC2780015          DOI: 10.2174/156720508786898451

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  133 in total

Review 1.  Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.

Authors:  D A Butterfield; J Drake; C Pocernich; A Castegna
Journal:  Trends Mol Med       Date:  2001-12       Impact factor: 11.951

2.  Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.

Authors:  X Zhu; R J Castellani; A Takeda; A Nunomura; C S Atwood; G Perry; M A Smith
Journal:  Mech Ageing Dev       Date:  2001-12       Impact factor: 5.432

3.  Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.

Authors:  R E Mrak; J G Sheng; W S Griffin
Journal:  J Neuropathol Exp Neurol       Date:  1996-03       Impact factor: 3.685

4.  4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

Authors:  L M Sayre; D A Zelasko; P L Harris; G Perry; R G Salomon; M A Smith
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

5.  p38 kinase is activated in the Alzheimer's disease brain.

Authors:  K Hensley; R A Floyd; N Y Zheng; R Nael; K A Robinson; X Nguyen; Q N Pye; C A Stewart; J Geddes; W R Markesbery; E Patel; G V Johnson; G Bing
Journal:  J Neurochem       Date:  1999-05       Impact factor: 5.372

6.  Apolipoprotein E allele-dependent antioxidant activity in brains with Alzheimer's disease.

Authors:  A Tamaoka; F Miyatake; S Matsuno; K Ishii; S Nagase; N Sahara; S Ono; H Mori; K Wakabayashi; S Tsuji; H Takahashi; S Shoji
Journal:  Neurology       Date:  2000-06-27       Impact factor: 9.910

Review 7.  Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging.

Authors:  J C de la Torre
Journal:  Gerontology       Date:  1997       Impact factor: 5.140

8.  Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis.

Authors:  C Atzori; B Ghetti; R Piva; A N Srinivasan; P Zolo; M B Delisle; S S Mirra; A Migheli
Journal:  J Neuropathol Exp Neurol       Date:  2001-12       Impact factor: 3.685

Review 9.  Radical AGEing in Alzheimer's disease.

Authors:  M A Smith; L M Sayre; V M Monnier; G Perry
Journal:  Trends Neurosci       Date:  1995-04       Impact factor: 13.837

10.  Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

Authors:  Carlos Opazo; Xudong Huang; Robert A Cherny; Robert D Moir; Alex E Roher; Anthony R White; Roberto Cappai; Colin L Masters; Rudolph E Tanzi; Nibaldo C Inestrosa; Ashley I Bush
Journal:  J Biol Chem       Date:  2002-08-20       Impact factor: 5.157

View more
  90 in total

1.  Humanin protects cortical neurons from ischemia and reperfusion injury by the increased activity of superoxide dismutase.

Authors:  Shen-Ting Zhao; Xiao-Tian Huang; Ce Zhang; Ya Ke
Journal:  Neurochem Res       Date:  2011-09-21       Impact factor: 3.996

Review 2.  Calcium and mitochondrial reactive oxygen species generation: how to read the facts.

Authors:  Vera Adam-Vizi; Anatoly A Starkov
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 3.  Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.

Authors:  Xiongwei Zhu; George Perry; Mark A Smith; Xinglong Wang
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis.

Authors:  William H Hoffman; Sandra L Siedlak; Yang Wang; Rudy J Castellani; Mark A Smith
Journal:  Brain Res       Date:  2010-10-30       Impact factor: 3.252

5.  The common biological basis for common complex diseases: evidence from lipoprotein lipase gene.

Authors:  Cui Xie; Zeng Chan Wang; Xiao Feng Liu; Mao Sheng Yang
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

6.  Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease.

Authors:  Cynthia A Massaad; Taneasha M Washington; Robia G Pautler; Eric Klann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-03       Impact factor: 11.205

7.  Generation and propagation of yeast prion [URE3] are elevated under electromagnetic field.

Authors:  Hui-Yong Lian; Kang-Wei Lin; Chuanjun Yang; Peng Cai
Journal:  Cell Stress Chaperones       Date:  2017-12-06       Impact factor: 3.667

8.  Negative Conditioning of Mitochondrial Dysfunction in Age-related Neurodegenerative Diseases.

Authors:  Sharmelee Selvaraji; Luting Poh; Venkateswaran Natarajan; Karthik Mallilankaraman; Thiruma V Arumugam
Journal:  Cond Med       Date:  2019-02

Review 9.  Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.

Authors:  Rituraj Niranjan
Journal:  Mol Neurobiol       Date:  2013-02-19       Impact factor: 5.590

10.  Animal models for Alzheimer's disease and frontotemporal dementia: a perspective.

Authors:  Jürgen Götz; Naeman N Götz
Journal:  ASN Neuro       Date:  2009-11-09       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.